These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
363 related items for PubMed ID: 21119603
1. FGF8b oncogene mediates proliferation and invasion of Epstein-Barr virus-associated nasopharyngeal carcinoma cells: implication for viral-mediated FGF8b upregulation. Lui VW, Yau DM, Cheung CS, Wong SC, Chan AK, Zhou Q, Wong EY, Lau CP, Lam EK, Hui EP, Hong B, Hui CW, Chan AS, Ng PK, Ng YK, Lo KW, Tsang CM, Tsui SK, Tsao SW, Chan AT. Oncogene; 2011 Mar 31; 30(13):1518-30. PubMed ID: 21119603 [Abstract] [Full Text] [Related]
2. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma. Verhoeven RJ, Tong S, Zhang G, Zong J, Chen Y, Jin DY, Chen MR, Pan J, Chen H. J Virol; 2016 Jul 15; 90(14):6475-88. PubMed ID: 27147748 [Abstract] [Full Text] [Related]
3. LMP1 stimulates the transcription of eIF4E to promote the proliferation, migration and invasion of human nasopharyngeal carcinoma. Zhao Y, Pang TY, Wang Y, Wang S, Kang HX, Ding WB, Yong WW, Bie YH, Cheng XG, Zeng C, Yao YH, Li Q, Hu XR. FEBS J; 2014 Jul 15; 281(13):3004-18. PubMed ID: 24814906 [Abstract] [Full Text] [Related]
4. Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion. Ho CH, Chen CL, Li WY, Chen CJ. Carcinogenesis; 2009 Aug 15; 30(8):1443-51. PubMed ID: 19483191 [Abstract] [Full Text] [Related]
6. Activation of the FGFR1 signalling pathway by the Epstein-Barr virus-encoded LMP1 promotes aerobic glycolysis and transformation of human nasopharyngeal epithelial cells. Lo AK, Dawson CW, Young LS, Ko CW, Hau PM, Lo KW. J Pathol; 2015 Oct 15; 237(2):238-48. PubMed ID: 26096068 [Abstract] [Full Text] [Related]
7. Twist and epithelial-mesenchymal transition are induced by the EBV oncoprotein latent membrane protein 1 and are associated with metastatic nasopharyngeal carcinoma. Horikawa T, Yang J, Kondo S, Yoshizaki T, Joab I, Furukawa M, Pagano JS. Cancer Res; 2007 Mar 01; 67(5):1970-8. PubMed ID: 17332324 [Abstract] [Full Text] [Related]
8. Mitogen- and stress-activated Kinase 1 mediates Epstein-Barr virus latent membrane protein 1-promoted cell transformation in nasopharyngeal carcinoma through its induction of Fra-1 and c-Jun genes. Li B, Wan Z, Huang G, Huang Z, Zhang X, Liao D, Luo S, He Z. BMC Cancer; 2015 May 10; 15():390. PubMed ID: 25958199 [Abstract] [Full Text] [Related]
9. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma. Lo AK, Lung RW, Dawson CW, Young LS, Ko CW, Yeung WW, Kang W, To KF, Lo KW. J Pathol; 2018 Oct 10; 246(2):180-190. PubMed ID: 29968360 [Abstract] [Full Text] [Related]
10. Expression of immune-related molecules in primary EBV-positive Chinese nasopharyngeal carcinoma: associated with latent membrane protein 1 (LMP1) expression. Li J, Zhang XS, Xie D, Deng HX, Gao YF, Chen QY, Huang WL, Masucci MG, Zeng YX. Cancer Biol Ther; 2007 Dec 10; 6(12):1997-2004. PubMed ID: 18087217 [Abstract] [Full Text] [Related]
11. NF-κB-mediated transcriptional upregulation of TNFAIP2 by the Epstein-Barr virus oncoprotein, LMP1, promotes cell motility in nasopharyngeal carcinoma. Chen CC, Liu HP, Chao M, Liang Y, Tsang NM, Huang HY, Wu CC, Chang YS. Oncogene; 2014 Jul 10; 33(28):3648-59. PubMed ID: 23975427 [Abstract] [Full Text] [Related]
12. STAT3 activation contributes directly to Epstein-Barr virus-mediated invasiveness of nasopharyngeal cancer cells in vitro. Lui VW, Wong EY, Ho Y, Hong B, Wong SC, Tao Q, Choi GC, Au TC, Ho K, Yau DM, Ma BB, Hui EP, Chan AS, Tsang CM, Tsao SW, Grandis JR, Chan AT. Int J Cancer; 2009 Oct 15; 125(8):1884-93. PubMed ID: 19588483 [Abstract] [Full Text] [Related]
13. Inhibition of the LKB1-AMPK pathway by the Epstein-Barr virus-encoded LMP1 promotes proliferation and transformation of human nasopharyngeal epithelial cells. Lo AK, Lo KW, Ko CW, Young LS, Dawson CW. J Pathol; 2013 Jul 15; 230(3):336-46. PubMed ID: 23592276 [Abstract] [Full Text] [Related]
14. Involvement of recepteur d'origine nantais receptor tyrosine kinase in Epstein-Barr virus-associated nasopharyngeal carcinoma and its metastasis. Chou YC, Chen CL, Yeh TH, Lin SJ, Chen MR, Doong SL, Lu J, Tsai CH. Am J Pathol; 2012 Nov 15; 181(5):1773-81. PubMed ID: 22974584 [Abstract] [Full Text] [Related]
15. Upregulation of endocan by Epstein-Barr virus latent membrane protein 1 and its clinical significance in nasopharyngeal carcinoma. Yu PH, Chou SF, Chen CL, Hung H, Lai CY, Yang PM, Jeng YM, Liaw SF, Kuo HH, Hsu HC, Chen JY, Wang WB. PLoS One; 2013 Nov 15; 8(12):e82254. PubMed ID: 24340011 [Abstract] [Full Text] [Related]
16. K252a induces anoikis-sensitization with suppression of cellular migration in Epstein-Barr virus (EBV)--associated nasopharyngeal carcinoma cells. Ng YK, Wong EY, Lau CP, Chan JP, Wong SC, Chan AS, Kwan MP, Tsao SW, Tsang CM, Lai PB, Chan AT, Lui VW. Invest New Drugs; 2012 Feb 15; 30(1):48-58. PubMed ID: 20694504 [Abstract] [Full Text] [Related]
17. Phenotypic alterations induced by the Hong Kong-prevalent Epstein-Barr virus-encoded LMP1 variant (2117-LMP1) in nasopharyngeal epithelial cells. Lo AK, Huang DP, Lo KW, Chui YL, Li HM, Pang JC, Tsao SW. Int J Cancer; 2004 May 10; 109(6):919-25. PubMed ID: 15027126 [Abstract] [Full Text] [Related]
19. SPLUNC1 reduces the inflammatory response of nasopharyngeal carcinoma cells infected with the EB virus by inhibiting the TLR9/NF-κB pathway. Ou C, Sun Z, Zhang H, Xiong W, Ma J, Zhou M, Lu J, Zeng Z, Bo X, Chen P, Li G, Li X, Li X. Oncol Rep; 2015 Jun 10; 33(6):2779-88. PubMed ID: 25891128 [Abstract] [Full Text] [Related]
20. Pathogenic role of Epstein-Barr virus latent membrane protein-1 in the development of nasopharyngeal carcinoma. Yoshizaki T, Kondo S, Wakisaka N, Murono S, Endo K, Sugimoto H, Nakanishi S, Tsuji A, Ito M. Cancer Lett; 2013 Aug 28; 337(1):1-7. PubMed ID: 23689138 [Abstract] [Full Text] [Related] Page: [Next] [New Search]